Elite Wealth Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-6,878	Closed	-$654K	–	42
2019 Q4	$654K	Sell	6,878 -53	-0.8%	-$4.58K	0.63%	18
2019 Q3	$528K	Sell	6,931 -483	-7%	-$40.1K	0.73%	19
2019 Q2	$650K	Sell	7,414 -531	-7%	-$45.3K	0.88%	15
2019 Q1	$719K	Sell	7,945 -1,120	-12%	-$95.3K	1.33%	15
2018 Q4	$650K	Buy	9,065 +160	+2%	+$12.9K	0.63%	32
2018 Q3	$854K	Sell	8,905 -23	-0.3%	-$2.23K	0.68%	33
2018 Q2	$850K	Buy	8,928 +459	+5%	+$42.2K	0.72%	32
2018 Q1	$743K	Buy	8,469 +244	+3%	+$22.3K	0.69%	35
2017 Q4	$698K	Buy	+8,225	New	+$689K	0.71%	37
2016 Q3	$796K	Sell	12,012 -2,791	-19%	-$173K	1.32%	22
2016 Q2	$800K	Sell	14,803 -2,831	-16%	-$155K	1.32%	24
2016 Q1	$910K	Buy	17,634 +1,509	+9%	+$78.4K	1.29%	23
2015 Q4	$1.13M	Buy	16,125 +5,097	+46%	+$348K	1.7%	20
2015 Q3	$686K	Sell	11,028 -3,762	-25%	-$296K	1.13%	39
2015 Q2	$1.24M	Sell	14,790 -2,037	-12%	-$158K	1.31%	27
2015 Q1	$1.26M	Buy	+16,827	New	+$1.18M	1.12%	33